NeoGenomics (NASDAQ: NEO) reported Q4 EPS of $0.05, $0.01 better than the analyst estimate of $0.04. Revenue for the quarter came in at $67.8 million versus the consensus estimate of $66.25 million.

GUIDANCE:

NeoGenomics sees FY2018 EPS of $0.15-$0.20, versus the consensus of $0.21. NeoGenomics sees FY2018 revenue of $260-270 million, versus the consensus of $281.06 million.

For earnings history and earnings-related data on NeoGenomics (NEO) click here.